2015 - The Walter E. Stamm Mentor Award, Infectious Diseases Society of America
The scientist’s investigation covers issues in Internal medicine, Surgery, Transplantation, Immunology and Bacteremia. His biological study spans a wide range of topics, including Gastroenterology and Mycosis. The various areas that David R. Snydman examines in his Surgery study include Adverse effect, Clinical trial and Confidence interval.
He has researched Transplantation in several fields, including Congenital cytomegalovirus infection, Ganciclovir, Betaherpesvirinae and Human cytomegalovirus. His Immunology research integrates issues from Penicillin, Lactobacillus GG and Cefuroxime. His Bacteremia research incorporates elements of Enterococcus, Staphylococcus aureus, Drug resistance and Intensive care medicine.
David R. Snydman spends much of his time researching Internal medicine, Immunology, Microbiology, Transplantation and Surgery. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Bacteremia. His studies in Bacteremia integrate themes in fields like Prospective cohort study and Intensive care medicine.
His Microbiology research includes themes of Vancomycin and Bacteroides. His work deals with themes such as Immunosuppression, Betaherpesvirinae, Human cytomegalovirus and Ganciclovir, which intersect with Transplantation. David R. Snydman has included themes like Incidence and Confidence interval in his Surgery study.
David R. Snydman mainly investigates Internal medicine, Congenital cytomegalovirus infection, Clostridium difficile, Microbiology and Vancomycin. Internal medicine and Gastroenterology are frequently intertwined in his study. His Congenital cytomegalovirus infection study introduces a deeper knowledge of Immunology.
His Immunology study incorporates themes from Fecal bacteriotherapy, Antimicrobial and Susceptibility testing. His work is dedicated to discovering how Microbiology, Agar are connected with Toxin, Bifidobacterium animalis and Gastrointestinal tract and other disciplines. His Vancomycin study combines topics from a wide range of disciplines, such as Antibiotics, Metronidazole and Bile acid.
His primary scientific interests are in Internal medicine, Clostridium difficile, Microbiology, Vancomycin and Agar dilution. David R. Snydman interconnects Gastroenterology and Congenital cytomegalovirus infection in the investigation of issues within Internal medicine. The study incorporates disciplines such as Liver transplantation and Severity of illness in addition to Gastroenterology.
His studies deal with areas such as Transplantation and Bacteroides as well as Clostridium difficile. He specializes in Microbiology, namely Antibiotic resistance. His work carried out in the field of Agar dilution brings together such families of science as Toxin and Feces.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp.
Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
Ioana Bica;Barbara McGovern;Barbara McGovern;Rakesh Dhar;David Stone;David Stone.
Clinical Infectious Diseases (2001)
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
M. Hong Nguyen;James E. Peacock;Arthur J. Morris;David C. Tanner.
The American Journal of Medicine (1996)
Epidemiology of sepsis syndrome in 8 academic medical centers.
Kenneth E. Sands;David W. Bates;Paul N. Lanken;Paul S. Graman.
Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients
Snydman Dr;Werner Bg;Heinze-Lacey B;Berardi Vp.
The New England Journal of Medicine (1987)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens.
The New England Journal of Medicine (2017)
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Mitchell P. Fink;David R. Snydman;Michael S. Niederman;Kenneth V. Leeper Jr..
Antimicrobial Agents and Chemotherapy (1994)
Risk and safety of probiotics.
Shira Doron;David R. Snydman.
Clinical Infectious Diseases (2015)
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
Victor L. Yu;Christine C. C. Chiou;Charles Feldman;Ake Ortqvist.
Clinical Infectious Diseases (2003)
Therapeutic Approaches in Patients With Candidemia: Evaluation in a Multicenter, Prospective, Observational Study
M. Hong Nguyen;James E. Peacock;David C. Tanner;Arthur J. Morris.
JAMA Internal Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: